Pharmatech Associates has established an extensive network within the regulated life sciences industry that it leverages to support licensing and alliance services for our clients.

Opportunity Search
For most biotechnology, biopharmaceutical, pharmaceutical and medical device companies, internal product development constitutes only one arm of their business strategy. Pharmatech helps companies seeking to expand their business activities through collaborative development and partnering, including:

• Developing short-listed opportunities matching selection criteria
• Initiating dialogue between partnering companies
• Representing the client at meetings and conferences
• Conducting due diligence to ensure opportunities match alliance objectives

In- and Out-Licensing Support
Companies can find themselves strapped for the resources and expertise necessary to expand their business strategy, in these situations, Pharmatech assists clients with all levels of licensing support:

• Negotiation support with licensing, marketing and distribution agreements
• Product and technology acquisition/divestment
• Technology transfer support
• Identification of and contact with potential partners
• Communication management
• Term sheet negotiation

Commercial Agreements
Pharmatech has extensive expertise and experience in the development of contractual agreements for all facets of drug development. Our services include the design of:

• Supply Agreements - to set pricing and address security of supply issues
  
  
• Quality Agreements - to define the metrics and mechanisms associated with handling quality issues with suppliers
  
  
• Facility Reservation Agreements - to define the pricing, space, and responsibilities associated with utilizing a Contract Research
  Organization (CRO) or a Contract Manufacturing Organization (CMO)
  
  
• CRO or CMO Supply Agreement - to address the business elements of manufacturing and/or packaging and distributing products for our clients

Due Diligence Assessments

Pharmatech's knowledge as it relates to drug development and product commercialization affords us the ability to evaluate and assess the viability of potential technologies and their related operations. Pharmtatech has conducted due diligence assessments pertaining to manufacturing, supply chain and quality systems for both merger and acquisition (M&A) initiatives as well as in licensing of intellectual properties (IP). Pharmatech's depth of experience provides valuable advice and guidance and which are tractable, ensuring that all conclusions are in synch with our client's capabilities and strategic requirements.